PMID- 19541884 OWN - NLM STAT- MEDLINE DCOM- 20090917 LR - 20090622 IS - 0956-4624 (Print) IS - 0956-4624 (Linking) VI - 20 IP - 7 DP - 2009 Jul TI - A brief review of potential mechanisms of immune reconstitution inflammatory syndrome in HIV following antiretroviral therapy. PG - 447-52 LID - 10.1258/ijsa.2009.008521 [doi] AB - A subset of HIV-infected individuals who receive antiretroviral therapy (ART) develop a paradoxical pathological response that significantly increases morbidity and sometimes mortality. Following the induction of highly active ART, a rapid decline in the viral load results within weeks and coincides with a steep rise in the CD4(+) T-cell counts and immune hyperactivation. Although no mechanistic pathway has been elucidated for the development of immune reconstitution inflammatory syndrome (IRIS), it is thought that change in the nature of the immune response is a predominant factor in the development of reconstitution disease. In this article, we review the current state of knowledge in this field and provide a model for the development of IRIS. FAU - Mori, S AU - Mori S AD - The University of Texas Health Sciences Center, Houston, Internal Medicine Program, Houston, Texas, USA. shahram.mori@uth.tmc.edu FAU - Levin, P AU - Levin P LA - eng PT - Journal Article PT - Review PL - England TA - Int J STD AIDS JT - International journal of STD & AIDS JID - 9007917 SB - IM MH - *Antiretroviral Therapy, Highly Active MH - HIV Infections/*complications/*drug therapy/immunology MH - HIV-1 MH - Humans MH - Immune Reconstitution Inflammatory Syndrome/*etiology/immunology MH - Risk Factors RF - 58 EDAT- 2009/06/23 09:00 MHDA- 2009/09/18 06:00 CRDT- 2009/06/23 09:00 PHST- 2009/06/23 09:00 [entrez] PHST- 2009/06/23 09:00 [pubmed] PHST- 2009/09/18 06:00 [medline] AID - 20/7/447 [pii] AID - 10.1258/ijsa.2009.008521 [doi] PST - ppublish SO - Int J STD AIDS. 2009 Jul;20(7):447-52. doi: 10.1258/ijsa.2009.008521.